癌细胞中的铁灭耐药性:纳米颗粒用于组合疗法,作为溶液
Kodzo Prosper Adzavon1, Weijian Zhao1, Xuesong He1
1College of Chemistry and Life Science, Beijing University of Technology, Beijing, China.
Frontiers in pharmacology
|July 4, 2024
概括
铁灭,一种细胞死亡形式,显示出对抗癌症的希望,但面临阻力. 纳米粒子和组合疗法为克服瘤中铁灭性抵抗提供了新的策略.
科学领域:
- 在瘤学瘤学.
- 细胞生物学 细胞生物学
- 生物化学 生物化学
背景情况:
- 铁亡是一种受调节的细胞死亡 (RCD) 机制,由依赖铁的脂质过氧化驱动.
- 这是克服瘤耐药性的关键策略,但癌细胞可以对铁灭产生耐药性.
- 了解铁灭症诱导和抵抗机制对于癌症治疗至关重要.
研究的目的:
- 为了研究癌细胞中的铁灭诱导机制.
- 讨论癌细胞对铁亡的抗性及其潜在原因.
- 探索基于纳米粒子的策略和组合疗法,以克服铁灭性耐药性.
主要方法:
- 关于ferroptosis诱导和抵抗机制的文献综述.
- 对抑制铁灭的生物标志物的分析.
- 评估纳米粒子介导的铁灭诱导.
- 探索涉及铁灭,其他细胞死亡类型和免疫治疗的组合策略.
主要成果:
- 详细介绍了诱导铁亡的途径和癌细胞抵抗机制.
- 发现了新的抑制铁灭的生物标志物.
- 纳米颗粒显示出诱导铁亡和克服耐药性的潜力.
- 组合疗法 (ferroptosis与apoptosis,cuproptosis,自,免疫疗法) 提供了有前途的途径.
结论:
- 基于纳米粒子的铁灭诱导是一种可行的策略,可以绕过癌细胞的抗性.
- 将铁与其他细胞死亡方式和免疫疗法结合起来,可以增强抗瘤功效.
- 对这些组合策略的进一步研究有必要进行临床转化.
更多相关视频
08:02Isolation of Primary Cancer-Associated Fibroblasts from a Syngeneic Murine Model of Breast Cancer for the Study of Targeted Nanoparticles
Published on: May 14, 2021
5.6K
09:01Magnetic-, Acoustic-, and Optical-Triple-Responsive Microbubbles for Magnetic Hyperthermia and Pothotothermal Combination Cancer Therapy
Published on: May 22, 2020
3.1K
相关概念视频
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K
